Beyond Air Inc (XAIR) Stock Price, Quote & News

Company Profile

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiol...

Industry: Medical Devices

Sector: Healthcare

Phone: 516 665 8200

Website: www.beyondair.net

Address:

900 Stewart Avenue, Suite 301, Garden City, United States

Say_Whaaaat Aug. 26 at 1:45 PM

$XAIR almost zero volume 15 mins into session

0 · Reply

BigNik007 Aug. 22 at 1:53 PM

$XAIR Since the reverse split, I can't even trade it on the regular exchanges in Germany anymore...

0 · Reply

good7 Aug. 22 at 3:40 AM

$XAIR Why is it so highly rated by analysts?

2 · Reply

deerix Aug. 21 at 10:58 PM

$XAIR being able to cut your losses is the first step of becoming profitable. I always go for a stop loss at around 15%, unless I scale in or it is a long-term/lower risk investment.

0 · Reply

VernCapital Aug. 21 at 10:24 PM

$XAIR didn’t expect much and I suppose what can he really say. That said his job as publicly floated company is to be answerable and deliver investor value.

2 · Reply

rodolfommo Aug. 21 at 8:15 PM

$XAIR Honestly...this is likely going to under 1 again. Product is great but management is beyond awful. It seems tax loss harvesting season will be very productive.

2 · Reply

VernCapital Aug. 21 at 8:07 PM

$XAIR just pure capitulation.

0 · Reply

MavisBeacon Aug. 21 at 4:55 PM

$XAIR another low. I've never seen anything like this. Just straight down, day after day after day

3 · Reply

VernCapital Aug. 21 at 2:01 PM

$XAIR This.

1 · Reply

MavisBeacon Aug. 21 at 2:00 PM

$XAIR new all time low, every single day

0 · Reply

Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan

Aug 12, 2025, 7:40 PM EDT - 13 days ago

Beyond Air, Inc. (XAIR) Q1 2026 Earnings Call Transcript

Jul 25, 2025, 8:00 AM EDT - 4 weeks ago

Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast

Jul 22, 2025, 7:30 AM EDT - 5 weeks ago

Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.

Jun 17, 2025, 9:53 PM EDT - 2 months ago

Beyond Air, Inc. (XAIR) Q4 2025 Earnings Call Transcript

Jun 17, 2025, 4:32 PM EDT - 2 months ago

Beyond Air Stock Dips After Mixed Q4 Results: Here's What To Know

Jun 17, 2025, 4:01 PM EDT - 2 months ago

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Jun 16, 2025, 8:00 AM EDT - 2 months ago

Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH

Jun 16, 2025, 7:20 AM EDT - 2 months ago

Top Wall Street Forecasters Revamp Beyond Air Expectations Ahead Of Q4 Earnings

May 20, 2025, 8:00 AM EDT - 3 months ago

Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast

Apr 21, 2025, 4:05 PM EDT - 4 months ago

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

Apr 15, 2025, 4:05 PM EDT - 4 months ago

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

Apr 9, 2025, 4:05 PM EDT - 4 months ago

Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients' Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home

Mar 31, 2025, 8:00 AM EDT - 5 months ago

Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

Mar 24, 2025, 4:05 PM EDT - 5 months ago

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

Mar 11, 2025, 7:30 AM EDT - 6 months ago

Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

Mar 6, 2025, 4:05 PM EST - 6 months ago

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

Feb 10, 2025, 7:25 PM EST - 7 months ago

Beyond Air, Inc. (XAIR) Q3 2025 Earnings Call Transcript

Feb 10, 2025, 4:05 PM EST - 7 months ago

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

Feb 5, 2025, 9:29 AM EST - 7 months ago

Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

Jan 27, 2025, 4:05 PM EST - 7 months ago

Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Jan 24, 2025, 9:15 AM EST - 7 months ago

Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia

Dec 9, 2024, 11:00 AM EST - 9 months ago

National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products

Dec 3, 2024, 4:05 PM EST - 9 months ago

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy

Dec 2, 2024, 7:30 AM EST - 9 months ago

Beyond Air Receives CE Mark in Europe for the LungFit® PH System

Nov 26, 2024, 7:30 AM EST - 9 months ago

NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board

Nov 14, 2024, 4:05 PM EST - 10 months ago

Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 11, 2024, 7:56 PM EST - 10 months ago

Beyond Air, Inc. (XAIR) Q2 2025 Earnings Call Transcript

Nov 11, 2024, 4:05 PM EST - 10 months ago

Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

Oct 29, 2024, 4:22 PM EDT - 10 months ago

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Oct 7, 2024, 7:00 AM EDT - 11 months ago

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 2, 2024, 7:30 AM EDT - 11 months ago

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

Sep 27, 2024, 7:34 AM EDT - 11 months ago

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

Sep 27, 2024, 7:32 AM EDT - 11 months ago

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

Sep 27, 2024, 7:30 AM EDT - 11 months ago

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Sep 23, 2024, 8:00 AM EDT - 1 year ago

Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Jul 31, 2024, 4:15 PM EDT - 1 year ago

Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia

Jul 23, 2024, 4:05 PM EDT - 1 year ago

Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6

Jul 16, 2024, 4:05 PM EDT - 1 year ago

Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024

Jun 24, 2024, 5:48 PM EDT - 1 year ago

Beyond Air, Inc. (XAIR) Q4 2024 Earnings Call Transcript

Jun 24, 2024, 4:15 PM EDT - 1 year ago

Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Jun 24, 2024, 3:32 AM EDT - 1 year ago

Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday

EPAC OMIC ITI STOK

Jun 13, 2024, 4:05 PM EDT - 1 year ago

Beyond Air® Appoints David Webster as Chief Commercial Officer

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)

May 23, 2024, 4:09 PM EDT - 1 year ago

Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast

Mar 20, 2024, 9:00 AM EDT - 1 year ago

Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants

Feb 13, 2024, 2:37 AM EST - 1 year ago

Beyond Air, Inc. (XAIR) Q3 2024 Earnings Call Transcript

Feb 12, 2024, 4:05 PM EST - 1 year ago

Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024

Jan 18, 2024, 8:00 AM EST - 1 year ago

Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast

$Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors$

Dec 27, 2023, 7:30 AM EST - 1 year ago

Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors

Say_Whaaaat Aug. 26 at 1:45 PM

$XAIR almost zero volume 15 mins into session

0 · Reply

BigNik007 Aug. 22 at 1:53 PM

$XAIR Since the reverse split, I can't even trade it on the regular exchanges in Germany anymore...

0 · Reply

good7 Aug. 22 at 3:40 AM

$XAIR Why is it so highly rated by analysts?

2 · Reply

deerix Aug. 21 at 10:58 PM

$XAIR being able to cut your losses is the first step of becoming profitable. I always go for a stop loss at around 15%, unless I scale in or it is a long-term/lower risk investment.

0 · Reply

VernCapital Aug. 21 at 10:24 PM

$XAIR didn’t expect much and I suppose what can he really say. That said his job as publicly floated company is to be answerable and deliver investor value.

2 · Reply

rodolfommo Aug. 21 at 8:15 PM

$XAIR Honestly...this is likely going to under 1 again. Product is great but management is beyond awful. It seems tax loss harvesting season will be very productive.

2 · Reply

VernCapital Aug. 21 at 8:07 PM

$XAIR just pure capitulation.

0 · Reply

MavisBeacon Aug. 21 at 4:55 PM

$XAIR another low. I've never seen anything like this. Just straight down, day after day after day

3 · Reply

VernCapital Aug. 21 at 2:01 PM

$XAIR This.

1 · Reply

MavisBeacon Aug. 21 at 2:00 PM

$XAIR new all time low, every single day

0 · Reply

JarvisFlow Aug. 21 at 12:00 PM

D. Boral Capital updates rating for Beyond Air ( $XAIR ) to Buy, target set at 11.

0 · Reply

MavisBeacon Aug. 20 at 8:03 PM

$XAIR .1065 pre reverse split. All time low close. I guess it's just going down every single day now

1 · Reply

Prof_Gulliver Aug. 20 at 5:11 PM

$XAIR Ah, Lisi, always the incompetent nincompoop. Love his PR today where he can’t help himself but to say their “international coverage” extends to “2.7 billion people.” How about a PR that includes some dollar signs? He can’t, because he doesn't have any. You can’t get any more inept than this guy. And for those who missed the once-in-a-lifetime opportunity to buy XAIR at 20 cents pre-RS, you'll probably soon get the opportunity to by it at 20 cents -- Post-RS!

0 · Reply

VernCapital Aug. 20 at 3:58 PM

$XAIR charles mosseri had $33,000,000 in value here at one point. Today it’s with just $318,000

1 · Reply

VernCapital Aug. 20 at 3:31 PM

$XAIR don’t forget, Lisi said “this is an exciting time for investors”

0 · Reply

Ventil8 Aug. 20 at 2:52 PM

$XAIR I used to mock rubberneckers at crashes. Now I’m one, watching this stock spiral, popcorn in hand.

0 · Reply

midnite_clyde Aug. 20 at 2:21 PM

$XAIR If anyone thinks Carey or Lisi will let this go bankrupt they are nuts. The only wildcard is FDA timing.

1 · Reply

Say_Whaaaat Aug. 20 at 1:57 PM

$XAIR I finally closed out after several years. Sadly this won't be trading this time next year...

1 · Reply

MavisBeacon Aug. 20 at 1:39 PM

$XAIR and new all time lows. Never ends.

2 · Reply

good7 Aug. 20 at 12:29 PM

$XAIR 我が国で注目されるのか

0 · Reply

MavisBeacon Aug. 20 at 12:17 PM

$XAIR more good news. Let's see if the market cares. Currently .08 from the all time low despite making notable progress

1 · Reply

Jlloyd31 Aug. 20 at 12:10 PM

$XAIR beaten up low float name with pr. In 2.35. Low risk bear 52 week lows. Looking for volume surge

0 · Reply

Market Cap	11.76M
Revenue (ttm)	3.71M
Net Income (ttm)	-46.63M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,256.87%
Debt to Equity Ratio	0.95

Volume	69,400
Avg Vol	315,440
Day's Range	N/A - N/A
Shares Out	5.23M
Stochastic %K	38%
Beta	0.25
Analysts	Strong Sell
Price Target	$10.50